Fig. 6.
Fig. 6. Increased sensitivity of PAR-1-transfected B16F10 tumor cells to thrombin-induced impaired cell growth. / Wild-type (WT), empty plasmid-transfectant (EP), and PAR-1–transfected B16F10 cells (S14) were treated with 0, 0.5, and 1 U/mL thrombin (T) for 72 hours as in Figure 1, and then analyzed by the MTT assay. SEM is given for experiments performed in quadruplicate. Student ttest for difference between EP versus S14 at 0.5 U/mL thrombin,P < .02; S14 at 0 versus 0.5 U/mL, P < .05; WT or EP versus S14 at 1 U/mL, P < .01.

Increased sensitivity of PAR-1-transfected B16F10 tumor cells to thrombin-induced impaired cell growth.

Wild-type (WT), empty plasmid-transfectant (EP), and PAR-1–transfected B16F10 cells (S14) were treated with 0, 0.5, and 1 U/mL thrombin (T) for 72 hours as in Figure 1, and then analyzed by the MTT assay. SEM is given for experiments performed in quadruplicate. Student ttest for difference between EP versus S14 at 0.5 U/mL thrombin,P < .02; S14 at 0 versus 0.5 U/mL, P < .05; WT or EP versus S14 at 1 U/mL, P < .01.

Close Modal

or Create an Account

Close Modal
Close Modal